Most Recent Articles by Anna Kitabjian
Within the first 30 days of therapy, patients with COPD who began using long-acting bronchodilators had a 1.5-fold increased risk for cardiovascular events.
A clinical trial is underway to assess the safety and efficacy of dabigatran in intermediate-risk pulmonary embolism after completing 72 hours of heparin therapy.
Women who were exposed prenatally to polychlorinated biphenyls may have an increased risk of having children with asthma, hay fever, or eczema.
Researchers identified 4 specific symptoms that could be the basis for a pneumonia diagnosis.
Asthma exacerbations may be reduced in patients with eosinophilic asthma treated with benralizumab.